Newsroom | 5803 results

SAN FRANCISCO--(BUSINESS WIRE)--Ambience Healthcare, the leading AI platform for clinical documentation and revenue integrity, today announced the launch of Chart Chat for Nursing, the first EHR-integrated conversational AI tool for inpatient nursing. Built alongside inpatient nurses and nursing informatics teams, Chart Chat for Nursing addresses how to find, synthesize, and act on the information to coordinate and drive nursing care. Chart Chat for Nursing lives inside the EHR and lets nurses...

ATLANTA--(BUSINESS WIRE)--Jackson Healthcare®, the trusted authority in healthcare talent and workforce solutions, today announced it has been named to the newly published 2026 Fortune® 100 Best Companies to Work For® list recognizing organizations with exceptional workplace culture and high employee satisfaction. This marks the company’s third consecutive appearance in the prestigious lineup. Jackson Healthcare received this distinction based on confidential feedback from its associates nation...

CANTON, Mass.--(BUSINESS WIRE)--Hendry Regional Medical Center (Clewiston, FL), a critical access hospital in rural Hendry County, has signed for the MEDITECH Expanse EHR to replace four disparate legacy systems and unify patient information into a single patient record. Transitioning to the cloud-native Expanse platform is anticipated to yield significant operational and clinical benefits, including improved physician efficiency, reduced staff burnout, and long-term financial savings. “We are...

ONTARIO, Calif.--(BUSINESS WIRE)--One year after entering the Illinois market, Prime Healthcare and the Prime Healthcare Foundation have invested more than $104 million to enhance clinical care and operations, modernize infrastructure, and expand service lines, while preserving more than 13,000 hospital and healthcare jobs and creating more than 1,000 new roles across eight hospitals. With dedication to quality and health equity, Prime’s Illinois hospitals have earned national and state recogni...

TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (siège social : Chuo-ku, Tokyo ; président et directeur délégué : Toshiaki Nagasato) a annoncé aujourd’hui un investissement stratégique dans Centivax, Inc. (siège social : South San Francisco, Californie, États-Unis), une société de biotechnologie qui développe des vaccins et des traitements de nouvelle génération visant à offrir une protection universelle contre des cibles extrêmement diverses. Le programme principal de Centivax porte notam...

TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (oficina central: Chuo-ku, Tokio; presidente y director representante: Toshiaki Nagasato) anunció hoy una inversión estratégica en Centivax, Inc. (oficina central: South San Francisco, California, EE. UU.), una empresa de biotecnología que desarrolla vacunas y terapias de próxima generación para protección universal contra dianas muy diversas. El programa principal de Centivax incluye una vacuna estacional universal contra la influenza (Centi...

TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Ufficio centrale: Chuo-ku, Tokyo, Presidente e rappresentante delegato: Toshiaki Nagasato) ha annunciato oggi un investimento strategico in Centivax, Inc. (Ufficio centrale: South San Francisco, CA, USA), un'azienda biotecnologica che si dedica allo sviluppo di vaccini di prossima generazione e di terapie per una protezione universale contro bersagli estremamente diversi. Il programma leader di Centivax include un vaccino universale contro l...

TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (hoofdkantoor: Chuo-ku, Tokio; President en Vertegenwoordigend Directeur: Toshiaki Nagasato) heeft vandaag een strategische investering aangekondigd in Centivax, Inc. (hoofdkantoor: South San Francisco, CA, VS), een biotechnologiebedrijf dat vaccins en therapieën van de volgende generatie ontwikkelt voor universele bescherming tegen zeer diverse doelwitten. Het hoofdprogramma van Centivax omvat een universeel seizoensgriepvaccin (Centi-Flu 01...

TOKIO--(BUSINESS WIRE)--Die Meiji Seika Pharma Co., Ltd. (Hauptsitz: Chuo-ku, Tokio; President und Representative Director: Toshiaki Nagasato) gab heute eine strategische Investition in Centivax, Inc. (Hauptsitz: South San Francisco, CA, USA) bekannt, ein Biotechnologieunternehmen, das Impfstoffe und Therapien der nächsten Generation für einen universellen Schutz gegen ein breites Spektrum von Zielen entwickelt. Das Leitprogramm von Centivax umfasst einen universellen saisonalen Grippeimpfstoff...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and platforms, today debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American Organization for Nursing Leadership Conference. The IV Verify system is designed to streamline nursing workflows, save clinician time and support safer medication administration at the bedside. Baxter’s launch of the product is the result of a strategic and exclusive distrib...